Biotech Values

[Jonathan Robinson]

If nothing happens in another three months, I’ll reduce this number to $50M, and if nothing happens in another six months, I’ll say that the value is zero. JMHO, FWIW

Ahhhhhh, you are exactly (almost) matching the quarterly cash increases as long as sole generic status is maintained for Lovenox.

Jon